Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Anticoagulation versus placebo for heart failure in sinus rhythm.

Lip GY, Wrigley BJ, Pisters R.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD003336. doi: 10.1002/14651858.CD003336.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(3):CD003336.

PMID:
22696335
2.

Anticoagulation versus placebo for heart failure in sinus rhythm.

Lip GY, Shantsila E.

Cochrane Database Syst Rev. 2014 Mar 28;(3):CD003336. doi: 10.1002/14651858.CD003336.pub3. Review.

PMID:
24683002
3.

Anticoagulation for heart failure in sinus rhythm.

Lip GY, Gibbs CR.

Cochrane Database Syst Rev. 2001;(4):CD003336. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD003336.

PMID:
11687190
4.

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.

Shantsila E, Lip GY.

Cochrane Database Syst Rev. 2016 Sep 15;9:CD003333. [Epub ahead of print] Review.

PMID:
27629776
5.

Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.

Lip GY, Gibbs CR.

QJM. 2002 Jul;95(7):451-9. Review.

PMID:
12096150
7.

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.

Lip GY, Gibbs CR.

Cochrane Database Syst Rev. 2001;(4):CD003333. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD003333.

PMID:
11687189
8.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Review.

PMID:
22161375
9.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC.

Cochrane Database Syst Rev. 2004;(3):CD003186. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD003186.

PMID:
15266473
10.

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.

Lane DA, Raichand S, Moore D, Connock M, Fry-Smith A, Fitzmaurice DA; Steering Committee.

Health Technol Assess. 2013 Jul;17(30):1-188. doi: 10.3310/hta17300. Review.

11.

Antiplatelet and anticoagulation for patients with prosthetic heart valves.

Massel DR, Little SH.

Cochrane Database Syst Rev. 2013 Jul 9;(7):CD003464. doi: 10.1002/14651858.CD003464.pub2. Review.

PMID:
23839768
12.

Antiplatelet therapy and anticoagulation in patients with hypertension.

Griffin G.

Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.

13.

Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.

Prom R, Usedom JE, Dull RB.

Ann Pharmacother. 2014 Feb;48(2):226-37. doi: 10.1177/1060028013511058. Epub 2013 Nov 12. Review.

PMID:
24259641
14.

Antiplatelet and anticoagulation for patients with prosthetic heart valves.

Little SH, Massel DR.

Cochrane Database Syst Rev. 2003;(4):CD003464. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003464.

PMID:
14583979
15.
16.

Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B.

Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21. Review.

17.

Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.

Rengo G, Pagano G, Squizzato A, Moja L, Femminella GD, de Lucia C, Komici K, Parisi V, Savarese G, Ferrara N, Perrone-Filardi P, Leosco D.

PLoS One. 2013;8(1):e52952. doi: 10.1371/journal.pone.0052952. Epub 2013 Jan 2. Review.

18.

Vitamin K for improved anticoagulation control in patients receiving warfarin.

Mahtani KR, Heneghan CJ, Nunan D, Roberts NW.

Cochrane Database Syst Rev. 2014 May 15;(5):CD009917. doi: 10.1002/14651858.CD009917.pub2. Review.

PMID:
24832594
19.

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.

Salazar CA, del Aguila D, Cordova EG.

Cochrane Database Syst Rev. 2014 Mar 27;(3):CD009893. doi: 10.1002/14651858.CD009893.pub2. Review.

PMID:
24677203
20.

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S.

J Card Fail. 2004 Apr;10(2):101-12.

PMID:
15101020

Supplemental Content

Support Center